Results
|
621.
|
Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin. [electronic resource] by
- Ottone, Tiziana
- Zaza, Serena
- Divona, Mariadomenica
- Hasan, Syed Khizer
- Lavorgna, Serena
- Laterza, Serena
- Cicconi, Laura
- Panetta, Paola
- Di Giandomenico, Jonny
- Cittadini, Michela
- Ciardi, Claudia
- Montefusco, Enrico
- Franchi, Annibale
- Annino, Luciana
- Venditti, Adriano
- Amadori, Sergio
- Lo-Coco, Francesco
Producer: 20130620
In:
British journal of haematology vol. 161
Availability: No items available.
|
|
622.
|
|
|
623.
|
Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia. [electronic resource] by
- Cummins, K D
- Jane, S M
- Ninkovic, S
- Nikovic, S
- Bazargan, A
- Filshie, R
- Sutrave, G
- Hertzberg, M
- Scott, A
- Lane, S
- Yannakou, C K
- Ritchie, D
- D'Rozario, J
- Black, J
- Bavishi, K
- Wei, A
Producer: 20150916
In:
Blood cancer journal vol. 4
Availability: No items available.
|
|
624.
|
|
|
625.
|
Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKβ inhibitors. [electronic resource] by
- Park, Chun-Ho
- Lee, Chulho
- Yang, Jee Sun
- Joe, Bo-Young
- Chun, Kwangwoo
- Kim, Hyuntae
- Kim, Hye Yun
- Kang, Jong Soon
- Lee, Jangik I
- Kim, Myung-Hwa
- Han, Gyoonhee
Producer: 20150928
In:
Bioorganic & medicinal chemistry letters vol. 24
Availability: No items available.
|
|
626.
|
|
|
627.
|
|
|
628.
|
Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells. [electronic resource] by
- Wang, Ying
- Xu, Yingxi
- Li, Saisai
- Liu, Jia
- Xing, Yanyan
- Xing, Haiyan
- Tian, Zheng
- Tang, Kejing
- Rao, Qing
- Wang, Min
- Wang, Jianxiang
Producer: 20191025
In:
Journal of hematology & oncology vol. 11
Availability: No items available.
|
|
629.
|
|
|
630.
|
|
|
631.
|
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with flt3 mutational status. [electronic resource] by
- Marasca, R
- Maffei, R
- Zucchini, P
- Castelli, I
- Saviola, A
- Martinelli, S
- Ferrari, A
- Fontana, M
- Ravanetti, S
- Torelli, G
Producer: 20060818
In:
Leukemia vol. 20
Availability: No items available.
|
|
632.
|
|
|
633.
|
|
|
634.
|
|
|
635.
|
|
|
636.
|
|
|
637.
|
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapy. [electronic resource] by
- Daver, Naval
- Liu Dumlao, Theresa
- Ravandi, Farhad
- Pierce, Sherry
- Borthakur, Gautam
- Pemmaraju, Naveen
- Nazha, Aziz
- Faderl, Stefan
- Jabbour, Elias
- Garcia-Manero, Guillermo
- Cortes, Jorges
- Kantarjian, Hagop
- Quintás-Cardama, Alfonso
Producer: 20140512
In:
Clinical lymphoma, myeloma & leukemia vol. 13
Availability: No items available.
|
|
638.
|
|
|
639.
|
Structural modifications at the 6-position of thieno[2,3-d]pyrimidines and their effects on potency at FLT3 for treatment of acute myeloid leukemia. [electronic resource] by
- Kim, Hyuntae
- Lee, Chulho
- Yang, Jee Sun
- Choi, Seonghwi
- Park, Chun-Ho
- Kang, Jong Soon
- Oh, Soo Jin
- Yun, Jieun
- Kim, Myung-Hwa
- Han, Gyoonhee
Producer: 20170213
In:
European journal of medicinal chemistry vol. 120
Availability: No items available.
|
|
640.
|
|